Stabilization and sustained-release effect of Misoprostol with Methacrylate copolymer

International Journal of Pharmaceutics

Volumn 203, Issue 1-2, 2000, Pages 141-148

  Chen, David ^a   Tsay, Rong Jer ^a   Lin, Hue In ^a   Chen, Huilan ^a   Chao, Shou Chung ^a   Ku, Hao ^a  

^a Drug Delivery   (China)

Author keywords

Dissolution profile; Eudragit; Misoprostol; Stability; Sustained release effect

Indexed keywords

EUDRAGIT; MISOPROSTOL; POLYMETHACRYLIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

ACRYLIC RESINS; ANTI-ULCER AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; MISOPROSTOL; SOLUBILITY;

EID: 0034255252     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00451-8     Document Type: Article

References (17)

1. Agrawal N.M., Godiwala T., Arimura A., Dajani E.Z. Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage, a double-blind endoscopic study in human subjects. Gastrointest. Endosc. 32:1986;67-70.
2. Birnie G.G., Watkinson G., Shroff N.E., Akbar F.A. Double-blind comparison of two dosage regimens of Misoprostol in the treatment of duodenal ulceration. Dig. Dis. Sci. 33(10):1988;1269-1273.
3. Chen, D., Tsay, R., Lin, H., Lu, S., 1997. Improved Stabilization of prostaglandin drug, Eur. Patent Pending 97305242.6.
4. Chen, D., Tsay, R., Lin, H., Lu, S., 1999. Stabilization of prostaglandin drug, US Patent 5, 889, 051.
5. Collins P.W., Rappo R., Dajani E.Z. Chemistry and synthetic development of Misoprostol. Dig. Dis. Sic. 30(11):1985;114S-117.
6. Dajani E.Z., Wang B., Pei Y., Pan G., Chen S., Zheng Z., Li Y., Zhu W., Wang J., Yuan S., Yu Y., Yao Z.J. Misoprostol in the treatment of duodenal ulcers in the People's Republic of China: A comparative, double-blind, multicenter study. Drug Dev. Res. 27:1992;415-423.
7. Gladziwa U., Klotz U. Pharmacokinetic optimization of the treatment of peptic ulcer in patients with renal failure. Clin. Pharmacokinet. 27(5):1994;393-408.
8. Gullikson G.W., Loeffler R.F., Mehrotra D.V., Casler J.J., Bianchi R.G., Schmidt R.E., Khoshaba N., Perkins W.E. Polymeric delivery of the active isomer of Misoprostol reduces systemic availability and uterotonic activity. J. Pharmacol. Exp. Ther. 273:1995;1123-1131.
9. Herting R.L., Clay G.A. Overview of clinical safety with Misoprostol. Dig. Dis. Sic. 30(11):1985;185S-193.
10. Kararli T.T., Catalano T. Stabilization of Misoprostol with hydroxypropyl methylcellulose (HPMC) against degradation by water. Pharm. Res. 7(11):1990;1186-1189.
11. Kararli T.T., Catalano T., Needham T.E., Finnegan P.M. Mechanism of Misoprostol stabilization in hydroxypropyl methylcellulose. Adv. Exp. Med. Biol. 302:1991;275-289.
12. Majure P.A. Comparative efficacy of Misoprostol and cimetidine in the treatment of acute duodenal ulcer. Am. J. Med. 83:1987;23-26.
13. Okhamafe O.A., York P. Studies of interaction phenomena in aqueous-based film coatings containing soluble additives using thermal analysis techniques. J. Pharm. Sci. 77(5):1988;438-443.
14. Oth M., Franz M., Timmermans J., Möes A. The bilayer floating capsule: A stomach-directed drug delivery system for Misoprostol. Pharm. Res. 9(3):1992;298-302.
15. Perkins W.E., Bianchi R.G., Trement S.J., Collins P.W., Casler J.J., Fenton R.L., Wagner G.M., McGrath M.P., Stolzenbach J.C., Kowalski D.L., Gasieckii A.F., Forster D., Jones P.H. Polymer delivery of the active isomer of Misoprostol: A solution to the intestinal side effect problem. J. Pharmacol. Exp. Ther. 269:1994;151-156.
16. Sanvordeker D.R. Stabilization of 16-oxygenated prostanoic acid derivatives. US Patent. 4(301):1981;146.
17. Tremont S.J., Collins P.W., Perkins W.E., Fenton R.L., Forster D., Mcgrath M.P., Wagner G.M., Gasiecki A.F., Bianchi R.G., Casler J.J., Ponte C.M., Stolzenbach J.C., Jones P.H., Gardt J.K., Wise W.B. Catalytic functionalization of polymers: A novel approach to site specific delivery of Misoprostol to the stomach. J. Med. Chem. 36:1993;3087-3097.